Grethel Gorham

Grethel Gorham possesses extensive experience in the pharmaceutical industry, currently serving as Director of Cell Therapy Manufacturing Strategy and Business Operations at Bristol Myers Squibb since June 2020, after progressing through various roles including Associate Director and Senior Manager in QA Engineering for CAR T. Prior experience includes roles at Celgene as a QA Principal Specialist and Senior Specialist in Validation and Lab Oversight, and at Eli Lilly and Company in QA and research positions. Earlier in career development at ImClone Systems, Grethel held multiple QC roles. Educational qualifications include a Bachelor's degree in Chemistry from Montclair State University and a Master's degree in Business Administration with a concentration in Pharmaceutical Management from Stevens Institute of Technology.